A novel molecular probe:experimental study in vivo in nude mice bearing tumor

Rong-fu WANG,Meng LIU,Chun-li ZHANG,Ping YAN,Ming-ming YU,Li-juan DI,Hong-jie LIU,Feng-qin GUO

DOI: https://doi.org/10.3321/j.issn:1003-3289.2009.01.002

2009-01-01

Abstract:Objective: To validate hTERT antisense imaging agent as a novel molecular probe in nude mice bearing tumor, and to evaluate the potential application value. Methods: Antisense and sense molecular probes targeting hTERT mRNA was radiolabeled with technetium - 99m. The BALB/c nu/nu nude mice were inoculated with MCF-7 mammary tumor cells in the right upper limbs. Antisense or sense molecular probe was injected intravenously in nude mice bearing tumor. Biodistribution and imaging in vivo was performed periodically. All data were analyzed by the statistic software of SPSS 12.0. Results: The labeling efficiencies of molecular probe reached 76%±5%, the specific activity was up to 1850 kBq/μg, and the radiochemical purity was above 96% after purification. The molecular probe accumulated mostly in the kidney and liver. In comparison with radio activity concentration in tumor tissue and the tumor-to-nontumor (T/NT) ratio of antisense molecular probe, those of sense molecular probe were significantly lower (P<0.05). After injection of antisense molecular probe, the ratio of tumor-to-muscle (T/M) exceeded 8.8, and that of tumor-to-blood (T/B) reached 2.0 at 6 h. As for imaging in vivo, all nude mice possessed substantial abdomen radioactivity accumulation after injection of molecular probe. The hTERT-expressing xenografts were clearly imaged at 4 h till 8 h after administration of antisense molecular probe. On the contrary, the tumors were not clearly imaged at any time after injection of sense molecular probe. Conclusion: This in vivo study provided evidence that antisense molecular probe targeting hTERT mRNA could be used as a potential candidate for visualization of hTERT expression in carcinomas.